7 April, 2020
SAN FRANCISCO, March 17, 2020 /PRNewswire/ — Today, ClinCapture , Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, announced that it will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus. The decision to offer free EDC for BioPharma and Diagnostic companies conducting COVID-19 clinical trials was announced after the World Health Organization issued a statement that the confirmed number of COVID-19 cases has surpassed 100,000 globally.
ClinCapture is inspired by the response time, organization, and dedication to find solutions for COVID-19 demonstrated within the clinical research industry and would like to help these companies by offering free EDC for their trials. ClinCapture will be providing its Captivate® EDC through the philanthropic Weidley’s Wish program which normally provides EDC to non-profit organizations conducting Rare Disease/Orphan Disease trials.
“We are in a unique position in a unique point in history,” said ClinCapture CEO Scott Weidley. “Our commitment to act now will have a dramatic effect on our ability to help in the future.”
ClinCapture’s Captivate® EDC is a fully validated, cloud-hosted system designed to offer researchers more insight into their clinical data in order to bring treatments to market faster.
To learn more about how ClinCapture can support your COVID-19 trials, please reach out to covid19trials@ClinCapture .com. A ClinCapture team member will contact you to provide more information.
ClinCapture provides a powerful eClinical platform that enables sponsors and CROs to rapidly build and deploy studies, lower clinical trial costs, and streamline data capture processes. Offering a host of Private Clinical Cloud® solutions, ClinCapture’s technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions. For more information, please visit ClinCapture .com or follow us at @ClinCapture .
SOURCE ClinCapture , Inc.